Please login to the form below

Not currently logged in
Email:
Password:

Alfred Sandrock

This page shows the latest Alfred Sandrock news and features for those working in and with pharma, biotech and healthcare.

Biogen’s R&D chief Ehlers heads for the exit

Biogen’s R&D chief Ehlers heads for the exit

Ehlers is moving on to take the chief executive position at a new gene therapy start-up called Limelight Bio on 11 October, while Biogen’s chief medical officer Alfred Sandrock

Latest news

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Biogen's Douglas Williams departs for biotech start-up Biogen's Douglas Williams departs for biotech start-up

    Williams will be replaced by chief medical officer Alfred Sandrock and chief scientific officer Spyros Artavanis-Tsakonas, who will be handed joint responsibility for Biogen Research and Development. ... We are fortunate to have Al Sandrock and Spyros

  • Biogen Idec names VP for value-based medicine Biogen Idec names VP for value-based medicine

    Through his years of hands-on clinical experience, he has gained a truly unique understanding of the needs of MS patients,” said Alfred Sandrock, chief medical officer of Biogen Idec.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics